Laborie To Buy Cogentix For $239m

The deal adds Cogentix' Urgent PC neuromodulation system for urinary incontinence, PrimeSight cystoscopy system, and Macroplastique soft-tissue bulking agent to treat female stress urinary incontinence to Laborie's range of urology and gynecology products.

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.
Laborie will pay a 28% premium over the current market price to acquire the outstanding shares of Cogentix

Laborie Medical Technologies has agreed to acquire the remaining shares of Cogentix Medical Inc. for about $239m, adding the rapidly growing Minnesota company to its existing urology business.

Under the terms of the deal announced March 12, Mississauga, Ontario-based Laborie's wholly owned subsidiariesLM US Parent Inc.and Camden Merger...

More from Deals

More from Business